Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Ruxolitinib can cause a delayed skin reaction on the nose.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Mesotherapy with dutasteride improves hair growth and reduces symptoms in frontal fibrosing alopecia.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

HSA nanoparticles can improve tamoxifen delivery for breast cancer treatment, reducing side effects.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Dupilumab may help regrow hair in people with atopic dermatitis.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

The FDA approved a new Pfizer drug for hair loss in teens.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Dupilumab may help regrow hair in people with severe alopecia.